A Q4 2021 Earnings — Agilent Technologies, Inc. Revenue & Financial Results | Market Cap Arena

AAgilent Technologies, Inc.

$33B

Q4 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$1.7B+11.9% YoY

Gross Profit

$900M54.2% margin

Operating Income

$395M23.8% margin

Net Income

$442M26.6% margin

EPS (Diluted)

$1.45

QoQ Revenue Growth

+4.7%

Cash Flow

Operating Cash Flow

$441M

Free Cash Flow

$379M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$10.7B

Total Liabilities

$5.3B

Stockholders' Equity

$5.4B

Cash & Equivalents

$1.5B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.7B	$1.5B	+11.9%
Gross Profit	$900M	$788M	+14.2%
Operating Income	$395M	$299M	+32.1%
Net Income	$442M	$222M	+99.1%

Revenue Segments

Life Sciences and Applied Markets

$747M45%

Agilent CrossLab

$572M34%

Diagnostics and Genomics

$341M21%

Geographic Segments

Americas

$662M40%

Asia Pacific

$585M35%

Europe

$413M25%